Zylox-Tonbridge Medical Technolgy Co Ltd (818) Stock Price & News

All values in CNY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	287.76M	287.76M	316.02M	316.02M
Cost of goods sold	77.86M	77.86M	84.07M	84.07M
Cost of revenue	77.86M	77.86M	84.07M	84.07M
Research and development expenses	62.59M	62.59M	53.19M	53.19M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	87.34M	87.34M	89.82M	89.82M
Operating expense	147.43M	147.43M	143.33M	143.33M
Total operating expenses	225.29M	225.29M	227.40M	227.40M
Operating income	62.47M	62.47M	88.62M	88.62M
Other non operating income	-16.77M	-16.77M	4.79M	4.79M
EBT including unusual items	57.77M	57.77M	102.01M	102.01M
EBT excluding unusual items	58.45M	58.45M	101.54M	101.54M
Income tax expense	-3.82M	-3.82M	12.46M	12.46M
Effective tax rate	-6.60%	-6.60%	12.21%	12.21%
Other operating expenses	-2.49M	-2.49M	323.00K	323.00K
Net income	61.59M	61.59M	90.86M	90.86M
Net profit margin	21.40%	21.40%	28.75%	28.75%
Earnings per share	-	-	-	-
Interest and investment income	15.52M	15.52M	9.75M	9.75M
Interest expense	-	-	-1.45M	-1.45M
Net interest expenses	15.52M	15.52M	8.30M	8.30M
Depreciation and amortization charges	-	-	-	-
EBITDA	70.34M	70.34M	98.14M	98.14M
Gain or loss from assets sale	45.00K	45.00K	-	-

Finance